The test screens for genetic variations in enzymes that influences how the patient’s metabolism will process opioids. Physicians can use this information to adjust dosages and predict side effects.
More Articles on Pain Management:
Georgia’s Houston Medical Center May Expand Pain Clinic
DEA Schedules September National Prescription Drug Take-Back Day
New York Pain Consultants Partner With Medtronic on Physician Training
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.